ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Percentile
P100
Near historical high
vs 2Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$128.45M+172.9%
2024$47.06M-53.1%
2023$100.45M+310.8%
2022$-47.66M-134.6%
2021$-20.32M+61.7%
2020$-53.05M-393.4%
2019$18.08M-67.8%
2018$56.16M+181.9%
2017$-68.57M+43.6%
2016$-121.59M-